Immunizations for Preventable Diseases in Adults and Adolescents With HIV  February 25, 2026: The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV have been updated.  Varicella-Zoster Virus Disease  These guidelines are published in an electronic format and updated as changes occur in prevention and treatment science. All updates are developed by the subject…

9-22-2025: CDC published new Clinical Recommendations for twice-a-year injectable lenacapavir as an additional option for HIV prevention in the United States. The U.S. Food and Drug Administration approved injectable lenacapavir, a prescribed medication, for HIV pre-exposure prophylaxis (PrEP) in June 2025. This is a significant step forward in expanding prevention options and reflects decades of research, partnership,…

9-25-25: The Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) updated the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV. For a comprehensive list of recent updates, please see What’s New in the Guidelines. The updates to the guidelines are outlined below.  New Chapter Added to the Guidelines (Five Sections) These guidelines are…